SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ProMetic Life Sciences

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: axial5/23/2018 10:57:31 AM
   of 250
 
Plasma medications from paid donors are safe: federal panel

'There is no good evidence that medication made from the plasma of paid donors is unsafe or that compensating donors undermines the voluntary blood-collection system, according to a federal expert panel that examined Canada’s approach to procuring a life-saving drug made from the blood component. The long-awaited report stopped short of endorsing paid plasma – Health Canada instructed the panelists to synthesize the evidence, not make recommendations – but the report said that remunerating donors for their plasma may be necessary if Canada hopes to become less reliant on paid Americans for immune globulin.

[...]

Canada uses more IG per capita than any country except the United States, and domestic demand for the drug is growing by as much as 10 per cent a year. Yet Canadian donations account for only 17 per cent of the raw material needed to meet this country’s demand for IG and other plasma-derived drugs. The rest comes from paid donors in the United States.

[...]
Whitney Goulstone, the executive director of the Canadian Immunodeficiencies Patient Organization (CIPO,) said she was pleased that the panelists were open to tapping more unpaid and paid donors to increase domestic supply of IG. Her organization supports both types of donations. “We need to be able to guarantee a continued access of supply in Canada for our patients,” said Ms. Goulstone, who takes IG for her primary immunodeficiency. “We don’t believe that’s possible without compensation of some sort.” (CIPO is funded by donations from individual members and two drug companies that make IG.)

Barzin Bahardoust, the chief executive of Canadian Plasma Resources, said he was not surprised that the expert panel found that paying for plasma is safe and does not appear to hurt the voluntary-collection system.

“These are just facts,” he said.'

Jim
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext